Ligand Pharmaceuticals In shares owned by Amalgamated Bank
Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Amalgamated Bank
from 13F filings
Historical chart of Amalgamated Bank investment in Ligand Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Ligand Pharmaceuticals In held by Amalgamated Bank consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Ligand Pharmaceuticals In by Amalgamated Bank
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $998k | 5.6k | 177.11 |
| 2025-06-30 | $619k | 5.4k | 113.66 |
| 2025-03-31 | $564k | 5.4k | 105.22 |
| 2024-12-31 | $592k | 5.5k | 107.13 |
| 2024-09-30 | $535k | 5.3k | 100.02 |
| 2024-06-30 | $435k | 5.2k | 84.34 |
| 2024-03-31 | $388k | 5.3k | 73.12 |
| 2023-12-31 | $450k | 6.3k | 71.50 |
| 2023-09-30 | $386k | 6.4k | 59.85 |
| 2023-06-30 | $482k | 6.7k | 72.05 |
| 2023-03-31 | $491k | 6.7k | 73.53 |
| 2022-12-31 | $481k | 7.2k | 66.81 |
| 2022-09-30 | $620k | 7.2k | 86.11 |
| 2022-06-30 | $662k | 7.4k | 89.27 |
| 2022-03-31 | $829k | 7.4k | 112.48 |
| 2021-12-31 | $1.2M | 7.8k | 154.44 |
| 2021-09-30 | $1.1M | 7.9k | 139.36 |
| 2021-06-30 | $1.6M | 12k | 131.15 |
| 2021-03-31 | $334k | 2.2k | 152.23 |
| 2020-12-31 | $238k | 2.4k | 99.37 |
| 2020-09-30 | $226k | 2.4k | 95.32 |
| 2020-06-30 | $274k | 2.4k | 111.88 |
| 2020-03-31 | $207k | 2.9k | 72.56 |
| 2019-12-31 | $307k | 2.9k | 104.39 |
| 2019-09-30 | $305k | 3.1k | 99.54 |
| 2019-06-30 | $356k | 3.1k | 113.99 |
| 2019-03-31 | $425k | 3.4k | 125.70 |
| 2018-12-31 | $445k | 3.3k | 135.84 |
| 2018-09-30 | $398k | 1.4k | 274.67 |
| 2018-06-30 | $708k | 3.4k | 207.20 |
| 2018-03-31 | $489k | 3.0k | 165.26 |
| 2017-12-31 | $412k | 3.0k | 136.97 |
| 2017-09-30 | $384k | 2.8k | 136.07 |
| 2017-06-30 | $341k | 2.8k | 121.27 |
| 2017-03-31 | $267k | 2.5k | 105.95 |
| 2016-12-31 | $257k | 2.5k | 101.78 |
| 2016-09-30 | $224k | 2.2k | 101.91 |
| 2016-06-30 | $251k | 2.2k | 114.61 |